Hepatitis B
Mostrando 25-36 de 3037 artigos, teses e dissertações.
-
25. Seroprevalence of transfusion-transmissible infectious diseases at a hemotherapy service located in southwest Bahia, Brazil
ABSTRACT Introduction: The serological screening of blood donors has been instituted by the Brazilian Ministry of Health and is mandatory in the research on several diseases transmissible through blood transfusion. Blood banks need to establish a screening service capable of reducing associated transfusions risks. Objective: The objective of this study was
Hematol., Transfus. Cell Ther.. Publicado em: 25/11/2019
-
26. NEW IMMUNIZATION SCHEDULE EFFECTIVENESS AGAINST HEPATITIS B IN LIVER TRANSPLANTATION PATIENTS
RESUMO CONTEXTO: O transplante de fígado, apesar de ser um procedimento de elevado risco, está consolidado como recurso terapêutico para cura e melhoria da qualidade de vida de indivíduos acometidos por doenças. A prevenção da infecção pelo vírus da hepatite B através da vacinação tem sido a medida mais efetiva para reduzir complicações, dim
Arq. Gastroenterol.. Publicado em: 07/11/2019
-
27. Hepatitis C prevalence among men who have sex with men in Central Brazil
Abstract To assess the prevalence of hepatitis C virus infection among men who have sex with men (MSM) in Central Brazil, a cross-sectional study was conducted in the City of Goiânia, Central Brazil, using Respondent-Driven Sampling (RDS). All serum samples were tested for anti-HCV and also for alanine aminotransferase (ALT). Anti-HCV positive samples and/o
Braz J Infect Dis. Publicado em: 24/10/2019
-
28. [PROVISIONAL] Resistance mutations of NS3 and NS5b in treatment-naïve patients infected with Hepatitis C virus in Santa Catarina and Rio Grande do Sul States, Brazil
Abstract Hepatitis C virus (HCV) infection is a worldwide health problem. Nowadays, direct-acting antiviral agents (DAAs) are the main treatment; however, the high level of variability of HCV lead to development of resistance-associated variants (RAVs). Thus, look into the RAVs among infected patients is an important tool for monitoring the efficacy of the t
Genet. Mol. Biol.. Publicado em: 21/10/2019
-
29. Necrolytic acral erythema in a Chinese patient with hepatitis C and hepatitis B virus coinfection
Abstract: Necrolytic acral erythema is a distinct erythema that has been described as an extrahepatic manifestation of hepatitis C virus infection. Most reported cases have been in Africa, especially Egypt. We report the first case (to the best of our knowledge) of necrolytic acral erythema in a Chinese patient with HCV and HBV coinfection. We aim to increas
An. Bras. Dermatol.. Publicado em: 17/10/2019
-
30. Hepatitis B virus infection among oncohematologic disease patients in Central Brazil: prevalence, risk factors and immunization
ABSTRACT Introduction: Carriers of oncohematological diseases are at high risk for hepatitis B virus (HBV) infection. Objective and method: To investigate the epidemiology of HBV infection in Goiânia, Central Brazil, 322 individuals with oncohematological diseases (leukemias, Hodgkin lymphoma and non-Hodgkin lymphoma) were interviewed and blood samples we
Hematol., Transfus. Cell Ther.. Publicado em: 10/10/2019
-
31. Influence of antiretroviral therapy on bone metabolism of patients with chronic hepatitis B: a review
Abstract Hepatitis B is a major public health problem worldwide and associated with significant mortality. To prevent or delay the deleterious effects of chronic infection by the hepatitis B virus, patients should be carefully followed, and antiviral therapy indicated according to specific recommendations. Currently, available drugs inhibit viral replication
Rev. Soc. Bras. Med. Trop.. Publicado em: 03/10/2019
-
32. Serum regucalcin is a useful indicator of liver injury severity in patients with hepatitis B virus-related liver diseases
Regucalcin is a soluble protein that is principally expressed in hepatocytes. Studies of regucalcin have mainly been conducted in animals due to a lack of commercially available kits. We aimed to develop an enzyme-linked immunosorbent assay (ELISA) to quantify serum regucalcin in patients with hepatitis B virus (HBV)-related disease. High-titer monoclonal an
Braz J Med Biol Res. Publicado em: 30/09/2019
-
33. Exploratory spatial analysis of HBV cases in Brazil between 2005 and 2017
RESUMO Objetivo: Analisar o padrão de distribuição espacial dos casos de hepatite causada pelo vírus B (HBV) e a mortalidade atribuída a esse agravo em todo o território nacional, nos anos de 2005, 2016 e 2017. Métodos : Trata-se de um estudo ecológico de análise espacial, utilizando dados do Sistema de Informação de Agravos de Notificação e d
Rev. bras. epidemiol.. Publicado em: 26/09/2019
-
34. Application of the Respondent-Driven Sampling methodology in a biological and behavioral surveillance survey among female sex workers, Brazil, 2016
RESUMO Introdução: O método de amostragem Respondent-Driven Sampling (RDS) tem sido utilizado em inquéritos com populações-chave sob maior risco de infecção pelo HIV, como as mulheres trabalhadoras do sexo (MTS). Este artigo tem o objetivo de descrever a implementação do RDS entre MTS em 12 cidades brasileiras em 2016. Metodologia: Trata-se de um
Rev. bras. epidemiol.. Publicado em: 26/09/2019
-
35. Hepatitis B and Delta: clinical aspects of patients in the Brazilian Western Amazonia
RESUMO Objetivo: Analisar aspectos clínicos, sorológicos, bioquímicos e hematológicos entre pacientes infectados por vírus das hepatites B (VHB) e Delta (VHD). Método: Estudo transversal, descritivo, retrospectivo, realizado com pacientes cronicamente infectados por VHB e superinfectados por VHD. Resultados: Entre os 112 pacientes selecionados, 74%
Rev. Bras. Enferm.. Publicado em: 16/09/2019
-
36. Clinical and epidemiological aspects of microcephaly in the state of Piauí, northeastern Brazil, 2015-20166
Resumo Objetivos: Descrever os aspectos da epidemia de microcefalia no Estado do Piauí. Métodos: Foram incluídos todos os casos de microcefalia congênita confirmados no estado entre 2015-2016 (n = 100). Os formulários de investigação do Centro Regional de Referência em Microcefalia foram analisados. Os casos descartados (n = 63) foram usados como g
J. Pediatr. (Rio J.). Publicado em: 12/09/2019